The Ablynx vs. Unilever dispute, part 3: The source of the contractual dispute

In 2007-2008, clinical trials were performed in Bangladesh, followed by trials in India in 2011-2012, either by or under the control of Unilever; these trials involved the use of ARP1—a VHH antibody that targets a rotavirus—in children.